Gabather AB (OSTO:GABA) Valuation Rank

View and export this data going back to 2014. Start your Free Trial

What is Gabather AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Gabather AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Gabather AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Gabather AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gabather AB (OSTO:GABA) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Forskargatan 20J, Byggn 215 N, Sodertalje, SWE, 151 36

Website

https://www.gabather.com

Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.